We are live on ! Find out more
AH

Accretive Health
AH

Delisted

AH was delisted on the 14th of March, 2014.

7 hedge funds and large institutions have $26.1M invested in Accretive Health in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

42% less funds holding

Funds holding: 127 (-5)

67% less capital invested

Capital invested by funds: $79.4M → $26.1M (-$53.2M)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
7
Holders Change
-5
Holders Change %
-41.67%
% of All Funds
0.2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
2
Increased
4
Reduced
Closed
7
Calls
Puts
Net Calls
Net Calls Change

AH Hedge Fund Activity: Q3 2014 in Review

7 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q3 2014, worth a combined $26.1M — down 67% from $79.4M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of AH and 2 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 4 added.

The largest buyer was Accipiter Capital Management, opening a new position worth an estimated $6.93M. The largest seller was Jasper Ridge Partners, exiting entirely with an estimated $63.2M sold.

  • 7 institutional investors held Accretive Health (AH) as of Q3 2014, down from 12 in Q2 2014.
  • Funds reported $26.1M of Accretive Health stock for Q3 2014, down 67% quarter-over-quarter.
  • 2 funds opened new Accretive Health positions in Q3 2014 and 7 closed out, a net change of -5 holders.
  • The largest Accretive Health buyer in Q3 2014 was Accipiter Capital Management, an estimated $6.93M added.
  • The largest Accretive Health seller in Q3 2014 was Jasper Ridge Partners, an estimated $63.2M sold.

Based on aggregated 13F filings for Q3 2014.